大禹生物
(871970)
| 流通市值：6.17亿 | | | 总市值：9.96亿 |
| 流通股本：6904.09万 | | | 总股本：1.11亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 52,589,902.75 | 25,674,833.74 | 19,849,530.87 | 22,757,512.26 |
| 应收票据及应收账款 | 20,907,077.14 | 20,545,383.32 | 23,720,209.87 | 24,167,802.85 |
| 应收账款 | 20,907,077.14 | 20,545,383.32 | 23,720,209.87 | 24,167,802.85 |
| 预付款项 | 3,481,693.46 | 2,535,887.49 | 2,175,563.39 | 1,761,129.39 |
| 其他应收款合计 | 101,569.25 | 42,052.5 | 55,292.2 | 16,573.05 |
| 存货 | 23,189,556.19 | 19,147,617.4 | 22,978,526.59 | 26,794,482.01 |
| 其他流动资产 | 743,050.88 | 754,413.35 | 740,737.62 | 892,843.09 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 101,075,998.67 | 68,700,187.8 | 69,519,860.54 | 76,390,342.65 |
| 非流动资产: | | | | |
| 固定资产 | 275,067,805.52 | 281,630,446.71 | 290,700,115.04 | 296,702,261.28 |
| 在建工程 | 403,895.54 | - | - | 359,867.69 |
| 使用权资产 | 4,942,281.73 | - | - | - |
| 无形资产 | 25,222,268.97 | 25,519,804.38 | 23,890,941.3 | 23,923,354.62 |
| 长期待摊费用 | - | - | - | 6,272.62 |
| 递延所得税资产 | - | - | 624,731.44 | 624,731.44 |
| 其他非流动资产 | 19,360,351.64 | 17,533,495 | 16,702,854.88 | 16,819,359.73 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 324,996,603.4 | 324,683,746.09 | 331,918,642.66 | 338,435,847.38 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 426,072,602.07 | 393,383,933.89 | 401,438,503.2 | 414,826,190.03 |
| 流动负债: | | | | |
| 短期借款 | 79,100,000 | 60,060,431.37 | 56,700,000 | 66,000,000 |
| 应付票据及应付账款 | 7,110,757.36 | 7,518,860.21 | 8,426,884.56 | 8,414,868.03 |
| 应付账款 | 7,110,757.36 | 7,518,860.21 | 8,426,884.56 | 8,414,868.03 |
| 合同负债 | 1,606,288.25 | 1,259,629.98 | 3,403,787.68 | 1,788,751.47 |
| 应付职工薪酬 | 7,188,526.81 | 7,575,144.43 | 7,118,390.8 | 6,764,113.58 |
| 应交税费 | 237,599.81 | 545,284.4 | 581,800.55 | 189,968.2 |
| 其他应付款合计 | 254,852.66 | 209,605.66 | 313,520 | 253,606.5 |
| 一年内到期的非流动负债 | 76,441.37 | - | - | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 95,574,466.26 | 77,168,956.05 | 76,544,383.59 | 83,411,307.78 |
| 非流动负债: | | | | |
| 租赁负债 | 4,609,811.69 | - | - | - |
| 递延收益 | 35,762,082.27 | 22,849,165.63 | 23,702,915.65 | 24,556,665.67 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 40,371,893.96 | 22,849,165.63 | 23,702,915.65 | 24,556,665.67 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 135,946,360.22 | 100,018,121.68 | 100,247,299.24 | 107,967,973.45 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 111,360,400 | 111,360,400 | 111,360,400 | 111,360,400 |
| 资本公积 | 85,593,738.02 | 85,593,738.02 | 85,593,738.02 | 85,593,738.02 |
| 减:库存股 | 5,109,738.08 | 5,109,738.08 | 5,109,738.08 | 5,109,738.08 |
| 盈余公积 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 |
| 未分配利润 | 81,428,772.96 | 84,668,343.32 | 92,493,735.07 | 98,160,747.69 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 290,126,241.85 | 293,365,812.21 | 301,191,203.96 | 306,858,216.58 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 290,126,241.85 | 293,365,812.21 | 301,191,203.96 | 306,858,216.58 |
| 负债和股东权益合计 | 426,072,602.07 | 393,383,933.89 | 401,438,503.2 | 414,826,190.03 |
| 公告日期 | 2025-04-28 | 2025-04-28 | 2024-10-28 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |